JP2005065629A - Tea tablet and method for producing the same - Google Patents

Tea tablet and method for producing the same Download PDF

Info

Publication number
JP2005065629A
JP2005065629A JP2003302013A JP2003302013A JP2005065629A JP 2005065629 A JP2005065629 A JP 2005065629A JP 2003302013 A JP2003302013 A JP 2003302013A JP 2003302013 A JP2003302013 A JP 2003302013A JP 2005065629 A JP2005065629 A JP 2005065629A
Authority
JP
Japan
Prior art keywords
tea
tablet
tablets
mixture
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003302013A
Other languages
Japanese (ja)
Inventor
Masaki Hasegawa
正樹 長谷川
Yoko Taniguchi
洋子 谷口
Takeshi Hibino
剛 日比野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mie Prefecture
Original Assignee
Mie Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mie Prefecture filed Critical Mie Prefecture
Priority to JP2003302013A priority Critical patent/JP2005065629A/en
Publication of JP2005065629A publication Critical patent/JP2005065629A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide tea tablets intended for improving productivity and product stability through including tea content as much as possible and solving impact damages such as capping and sticking, and having hardness enough to take with water and eat by chewing, and to provide a method for producing the tablets. <P>SOLUTION: This method for producing the tablets comprises mixing silicic anhydride with vegetable hardened oil or fish oil to make a mixture, mixing the mixture with tea powder, and forming the mixed mixture into tablets without addition of water and alcohols. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は医薬品類や健康食品として経口摂取される茶錠剤およびその製造方法に関する。   The present invention relates to a tea tablet to be taken orally as a pharmaceutical or a health food and a method for producing the tea tablet.

茶は古来より日本人の伝統的飲料として摂取されてきたが、嗜好品というよりもむしろ健康維持のためという位置付けになりつつある。緑茶は栽培された後、葉を葉柄や葉脈と分離して発酵させたり、あるいはそれらの混合物を発酵させたりしていろいろな種類の茶が生産される。しかし、いずれも飲用時に湯で抽出して食するのが一般的である。
近年、茶の有効成分が精力的に研究され、食事以外にも茶を摂取した方がより健康増進に有益であるという報告がなされている。この観点から、ご飯に振りかけて服用する「茶」顆粒が考案され市販されている。しかし、顆粒状茶は水やアルコールを使用して造粒するため原料茶粉末に比べて味や風合いが劣るという欠点があった。また、最近では、食事から離れていつでも好きなときに服用できる薬感覚,健康補助食品感覚の種々の「茶成分+α成分」錠剤が考案され、その技術内容が提案,公開されている(例えば、特許文献1〜4参照)。
Tea has been ingested as a traditional Japanese drink since ancient times, but it is becoming a health maintenance rather than a luxury product. After green tea has been cultivated, various types of tea are produced by fermenting leaves separated from petioles and veins, or by fermenting a mixture thereof. However, it is common to extract and eat with hot water when drinking.
In recent years, active ingredients of tea have been energetically studied, and it has been reported that taking tea in addition to meals is more beneficial for health promotion. From this point of view, “tea” granules to be sprinkled over rice have been devised and marketed. However, since granulated tea is granulated using water or alcohol, it has the disadvantage that its taste and texture are inferior to the raw tea powder. Recently, various “tea ingredients + α ingredients” tablets have been devised, and their technical contents have been proposed and published (for example, for example) (See Patent Documents 1 to 4).

特開2001−292702公報(従来技術1)JP 2001-292702 A (Prior Art 1) 特開平11−139981号公報(従来技術2)Japanese Patent Laid-Open No. 11-139981 (Prior Art 2) 特開平10−2210932号公報(従来技術3)JP 10-2210932 A (Prior Art 3) 特開平8−298931号公報(従来技術4)JP-A-8-298931 (prior art 4)

しかるに、従来技術1は茶粉末物を打錠してなる錠剤とあるが、主たる発明が茶葉の粉末化方法であって、詳細な説明でも「粉末物の錠剤化は公知の錠剤の形成方法を任意に選択することができる」とする記載にとどまっている。
従来技術2は「茶葉微粉末及び抹茶にオリゴ糖を混合した錠剤の製造方法」とあるが、オリゴ糖添加により茶の薬効を引き出す発明であって、錠剤化に関する具体的記載はなされていない。従来技術3は「抹茶の粉末に甘味料を混合し、更に寒天粉の増量剤を添加混同撹拌し、その後、錠剤状の形状に固形成型する抹茶錠の製造方法」であって、錠剤化技術は特に記載されていない。従来技術4は「粉末茶を水でペースト化し、押出成型後乾燥して錠剤を得る粉末茶錠の製造方法」であって、湿式錠剤の発明である。
However, although the prior art 1 is a tablet formed by tableting a tea powder, the main invention is a method for powdering tea leaves, and the detailed description also states that “tablet formation of powder is a known tablet formation method. “It can be arbitrarily selected”.
Prior art 2 is described as “a method for producing a tablet in which oligosaccharide is mixed with tea leaf fine powder and matcha tea”, but it is an invention that draws out the medicinal effects of tea by adding oligosaccharide, and there is no specific description regarding tableting. Prior art 3 is “a method for producing a matcha tablet in which a sweetener is mixed with powdered green tea, a bulking agent for agar powder is further added, mixed and stirred, and then solid-molded into a tablet shape”. Is not specifically described. Prior art 4 is “a method for producing a powdered tea tablet in which powdered tea is pasted with water, dried after extrusion and dried to obtain a tablet”, and is an invention of a wet tablet.

錠剤を商品として製造するときの大きな必須要件は、(1)錠剤用粉末が臼内に均一且つスムーズに充填されること、(2)圧縮成形に際しキャッピング(錠剤の層状割れ)やスティッキング(杵への付着)などの打撃障害があってはならないことである。これらを鑑みるとき、前記従来技術は錠剤の製造方法や製造技術等に関する記載がなく、良好な錠剤を製造できるとは限らない。すなわち、従来技術1は茶葉の粉末化技術に関するものであり錠剤製造方法について何ら言及しておらず、従来技術2,3は茶と他の有効成分の組み合わせにより茶含有有効成分の効果の増強を図ったものであり、錠剤の製造技術を開発したものではない。従って、錠剤を製品とした量産の可能性については未知である。圧縮成形に劣る茶粉末にあって、これまでの錠剤成形技術のみに頼ると量産が困難になる。従来技術4は湿式法によるものであり、湿潤、乾燥過程を経るため原料茶粉末に比べて味や風合いが劣るといった欠点を示すことが考えられ、また製造後の安定性が懸念される製造方法でもある。   The major essential requirements when manufacturing tablets as commercial products are: (1) The powder for tablets is uniformly and smoothly filled into the die, and (2) Capping (tablet cracking of tablets) and sticking (to a bag) during compression molding. There should be no damages such as damage). In view of these, the prior art does not describe a tablet manufacturing method, manufacturing technique, etc., and cannot always manufacture a good tablet. That is, Prior Art 1 relates to tea leaf powdering technology and does not mention any tablet manufacturing method, and Prior Art 2 and 3 enhance the effect of tea-containing active ingredients by combining tea with other active ingredients. It is intended and not a tablet manufacturing technology. Therefore, the possibility of mass production using tablets as products is unknown. The tea powder is inferior to compression molding, and mass production becomes difficult if only the conventional tablet molding technology is used. Prior art 4 is based on a wet method, and since it undergoes a wet and dry process, it may be considered to exhibit defects such as inferior taste and texture compared to the raw tea powder, and there is concern over stability after production. But there is.

本発明は上記問題点を解決するもので、茶成分をできる限り高含量にして、生産性向上と製品の安定性を図り、さらに水で服用したり噛んで食べたりすることのできる十分な硬さを有する茶錠剤およびその製造方法を提供することを目的とする。   The present invention solves the above-mentioned problems, and increases the tea content as much as possible to improve the productivity and stability of the product. Further, it is hard enough to be taken or chewed with water. It is an object of the present invention to provide a tea tablet having a thickness and a method for producing the same.

上記目的を達成すべく、請求項1に記載の発明の要旨は、茶粉末と無水ケイ酸を含有して打錠成形されてなることを特徴とする茶錠剤にある。請求項2の発明たる茶錠剤は、茶粉末と、無水ケイ酸と、植物性硬化油又は魚油と、を含有して打錠成形されてなることを特徴とする茶錠剤にある。請求項3の発明たる茶錠剤の製造方法は、無水ケイ酸に植物性硬化油又は魚油を混合し混合物を作製し、次いで該混合物と茶粉末とを混ぜ合わせ、その後、この混ぜ合わせた混合体を、水やアルコール類を添加することなく錠剤に成形することを特徴とする茶錠剤の製造方法にある。   In order to achieve the above object, the gist of the invention described in claim 1 resides in a tea tablet that is formed by tableting containing tea powder and silicic anhydride. A tea tablet according to a second aspect of the present invention is a tea tablet comprising a tea powder, silicic anhydride, and a vegetable hardened oil or fish oil, and is formed into a tablet. According to a third aspect of the present invention, there is provided a method for producing a tea tablet, comprising mixing silicic anhydride with vegetable hardened oil or fish oil to prepare a mixture, then mixing the mixture with tea powder, and then mixing the mixture. Is produced into a tablet without adding water or alcohols.

請求項1の発明のごとく、茶粉末と無水ケイ酸とを必須成分として含有すると、打錠中キャッピングやスティッキングなどの障害が発生せず、生産性向上を図ることができる。茶錠剤を製造するにあたって、無水ケイ酸を加えることによって成形性改善効果が得られる。
さらに請求項2,3のごとく、茶粉末と、無水ケイ酸と、植物性硬化油又は魚油と、を必須成分として含有して打錠成形されると、茶粉末を高含量にでき且つ得られた錠剤は充分な硬さを有し、キャッピングやスティッキングなどの取扱い上の問題は全く見られなくなる。服用時に口中で充分に噛み応えのある茶錠剤が得られる。錠剤成形時における茶粒子の流動性,充填性,成形性も向上する。請求項3のごとく、無水ケイ酸に植物性硬化油又は魚油を混合し混合物を作製し、次いで該混合物と茶粉末とを混ぜ合わせ、その後、この混ぜ合わせた混合体を錠剤に成形すると、無水ケイ酸と植物性硬化油又は魚油を混合によって分散性が高まっており、製品の安定化が図られる。水やアルコール類を添加しないいわゆる乾式法であって、原料茶粉末に比べて味や風合いが劣るといった湿式法にみられる欠点も解消する。
When tea powder and anhydrous silicic acid are contained as essential components as in the first aspect of the invention, obstacles such as capping and sticking during tableting do not occur, and productivity can be improved. In manufacturing a tea tablet, the moldability improvement effect can be obtained by adding silicic anhydride.
Furthermore, as described in claims 2 and 3, when tableting is carried out by containing tea powder, anhydrous silicic acid, vegetable hardened oil or fish oil as essential components, the tea powder can be obtained in a high content. The tablets have sufficient hardness, and handling problems such as capping and sticking are not seen at all. Tea tablets that are sufficiently chewy in the mouth when taken. The fluidity, filling and moldability of tea particles during tableting are also improved. As in claim 3, when a mixture is made by mixing vegetable hardened oil or fish oil with anhydrous silicic acid, and then mixing the mixture with tea powder, the mixture is then molded into a tablet. Dispersibility is enhanced by mixing silicic acid with vegetable hardened oil or fish oil, and the product can be stabilized. It is a so-called dry method in which water and alcohols are not added, and the disadvantages seen in the wet method, such as the taste and texture being inferior to the raw tea powder, are also eliminated.

以下、本発明に係る茶錠剤およびその製造方法について詳述する。本発明者らは茶粉末に予め植物性硬化油で均一に分散せしめた無水ケイ酸(微粒子二酸化ケイ素:食品添加物記載名称または軽質無水ケイ酸:日本薬局方記載名称)を添加混合し、成形性の優れた錠剤を得ることに成功した。無水ケイ酸は従来、分散助剤として使用されるものであったが、茶末にあっては成形性改善効果のあることを見出した。
茶粉末は一般的に圧縮成形性が劣るため、錠剤にし難い。錠剤の硬度は直径方向に圧縮して破壊するとき凡そ40N(略4kg)以上の硬度が必要といわれる(長谷川正樹、信田正行、大塚昭信、“乳糖−デンプン平型錠の圧縮性に関する研究”薬剤学、41、146、1981)。茶錠剤の場合、医薬品錠剤のように水で服用する以外に、噛んだりして服用することが考えられる。したがって口中で歯ごたえのあるような硬さをもたせることも必要と考えられる。表1に錠剤硬度と硬さ及び官能性との関係を示す。試料錠剤は乳糖/デンプン系の標準処方で製した。硬さ試験は、錠剤摩損度試験器(トヤマ産業株式会社製)中に錠剤10個を入れ、4分間回転させた後、錠剤の外観を観察した。官能性については、錠剤を口中に含み、歯で噛んで「噛み心地」を評価した。その結果、44N(略4.4kg)の硬度を示す錠剤は硬さ、官能性とも良好であった。
Hereinafter, the tea tablet and the production method thereof according to the present invention will be described in detail. The present inventors added and mixed silicic acid silicic acid (fine particle silicon dioxide: name of food additive or light silicic acid: name of Japanese pharmacopoeia), which was uniformly dispersed with vegetable hardened oil in advance into tea powder, and molded. We succeeded in obtaining tablets with excellent properties. Silica anhydride has been conventionally used as a dispersion aid, but it has been found that tea powder has an effect of improving moldability.
Since tea powder is generally inferior in compression moldability, it is difficult to make tablets. It is said that the hardness of tablets is about 40N (approximately 4kg) or more when broken in the diameter direction (Masaki Hasegawa, Masayuki Noda, Akinobu Otsuka, “Study on compressibility of lactose-starch flat tablets”) Gaku, 41 , 146, 1981). In the case of tea tablets, it is conceivable to take them by chewing in addition to taking them with water like pharmaceutical tablets. Therefore, it is considered necessary to have a hardness that is crunchy in the mouth. Table 1 shows the relationship between tablet hardness, hardness and functionality. Sample tablets were made with a standard formula of lactose / starch system. In the hardness test, 10 tablets were put in a tablet friability tester (manufactured by Toyama Sangyo Co., Ltd.) and rotated for 4 minutes, and then the appearance of the tablets was observed. Regarding sensory properties, a tablet was included in the mouth and chewed with teeth to evaluate “chewing comfort”. As a result, the tablet showing a hardness of 44 N (approximately 4.4 kg) was good in both hardness and functionality.

Figure 2005065629
Figure 2005065629

錠剤を作る際、予め原料粉末を均一に混合し、これを顆粒化してから圧縮成形するのが一般的である。これは製品の重量偏差を小さくして成形性を高めるためである。顆粒化する手段として、湿式法と乾式法がある。前者は水などで練合し、乾燥後一定の大きさの顆粒へサイズダウンする方法であり、後者は直接圧縮成形するか若しくはローラーコンパクターなどで強圧してフレークを成形しこれを破砕して顆粒を作る方法である。前者の場合、高い硬度が得られるため有用性が高い方法であるが、乾燥工程を経るため、風味や外観を重要視する食品などでは不適といわれる。後者は、熱や水分の影響がないため良好な品質を保持した錠剤が得られるが、高い硬度を得にくく、そのため微量添加で良好な圧縮成形性を発揮する賦形剤の添加を必要とする。本発明者らは、茶葉粉末の含有率70重量%(以下、単に「%」という。)以上の錠剤を目標として研究を行った。そこで茶葉粉末7重量部(以下、単に「部」という。)に対し予め造粒した糖アルコール(ソルビトール等5種類)顆粒3部を混合し、錠剤を得た。しかし200MPa(2トン)で圧縮成形したにもかかわらず、所望する硬度(40N以上)の錠剤は得られなかった(表2)。なお、打錠機や杵の負荷、打錠速度からみて通常は100〜150MPa(略1〜1.5トン)で圧縮できることが望ましい。   When making a tablet, it is common to uniformly mix the raw material powder in advance, granulate it, and then compress it. This is to reduce the weight deviation of the product and improve the moldability. As a means for granulating, there are a wet method and a dry method. The former is a method of kneading with water, etc., and reducing the size into granules of a certain size after drying, the latter is directly compressing or forming a flake by pressing with a roller compactor etc. and crushing this to granulate Is how to make. The former method is highly useful because high hardness can be obtained, but it is said to be unsuitable for foods that place importance on flavor and appearance because it undergoes a drying process. The latter is not affected by heat or moisture, so that tablets with good quality can be obtained. However, it is difficult to obtain high hardness, and therefore it is necessary to add excipients that exhibit good compression moldability with a small amount of addition. . The inventors of the present invention have conducted research with a target of tablets having a tea leaf powder content of 70% by weight (hereinafter simply referred to as “%”) or more. Accordingly, 7 parts by weight of tea leaf powder (hereinafter simply referred to as “parts”) was mixed with 3 parts of granulated sugar alcohol (5 types such as sorbitol) granules to obtain tablets. However, despite the compression molding at 200 MPa (2 tons), tablets with the desired hardness (40 N or more) were not obtained (Table 2). In view of the tableting machine, the load on the punch, and the tableting speed, it is usually desirable that compression is possible at 100 to 150 MPa (approximately 1 to 1.5 tons).

Figure 2005065629
Figure 2005065629

次に、表2で最も高い硬度を示したソルビトール顆粒を賦形剤とし、微量添加物の有効性の検討を行った。添加量は2%、圧縮圧200MPa(略2トン)、錠剤直径8.5mmである。その結果を表3に示す。無水ケイ酸が所望の硬度を示すことが分かった。   Next, sorbitol granules that showed the highest hardness in Table 2 were used as excipients to examine the effectiveness of trace additives. The addition amount is 2%, the compression pressure is 200 MPa (approximately 2 tons), and the tablet diameter is 8.5 mm. The results are shown in Table 3. It has been found that silicic anhydride exhibits the desired hardness.

Figure 2005065629
Figure 2005065629

無水ケイ酸の添加量と成形性について検討し、その結果を表4に示す。その結果、無水ケイ酸は0.5%の添加量であっても成形性に関し効果を示した。   The amount of silicic acid added and the moldability were examined, and the results are shown in Table 4. As a result, silicic acid anhydride showed an effect on moldability even when added in an amount of 0.5%.

Figure 2005065629
Figure 2005065629

茶粉末に無水ケイ酸を添加混合し、さらに別に製したソルビートール顆粒を混合して得た混合末をロータリー打錠機(株式会社菊水製作所製コレクト12HUK)を用いて打錠した(30rpm、1錠あたり重量:200mg)。その結果、少量成形時に比べて低い硬度を示したが、原因は大量し込みによる不均一混合であると判断した。無水ケイ酸は粒子サイズが15μm以下(実用的には3〜5μm)の微粉末であるため通常は凝集性が高く、したがって混合に際し分散性を高める必要がある。そこで分酸性向上を意図して、予め無水ケイ酸に対し植物性硬化油又は魚油を添加混合し、これを打錠用に供した。すなわち、無水ケイ酸に植物性硬化油又は魚油を混合し混合物を作製し、次いで該混合物と茶粉末とを混ぜ合わせ、その後、この混ぜ合わさった混合体を打錠機で錠剤に成形するのである。その結果、1:1以上の混合比において非混合時に比べて高い硬度を示した(表5)。   Silica was added to and mixed with the tea powder, and the mixed powder obtained by further mixing sorbitol granules produced separately was tableted using a rotary tableting machine (Collect 12HUK manufactured by Kikusui Seisakusho Co., Ltd.) (30 rpm, 1 tablet) Per weight: 200mg). As a result, the hardness was lower than that in small-scale molding, but the cause was judged to be non-uniform mixing due to mass penetration. Silicic anhydride is a fine powder having a particle size of 15 μm or less (practically 3 to 5 μm), and therefore usually has high cohesiveness. Therefore, it is necessary to increase dispersibility during mixing. Therefore, in order to improve the acidity, vegetable hardened oil or fish oil was added to and mixed with anhydrous silicic acid in advance and used for tableting. That is, a vegetable hardened oil or fish oil is mixed with silicic acid anhydride to prepare a mixture, and then the mixture and tea powder are mixed, and then the mixed mixture is formed into a tablet with a tableting machine. . As a result, the hardness was higher at a mixing ratio of 1: 1 or higher than when the mixture was not mixed (Table 5).

Figure 2005065629
Figure 2005065629

無水ケイ酸は凝集性が強いため、単に機械的に混合しても分散せず、充分な均一混合性の得られないためと考えられた。鋭意検討した結果、無水ケイ酸に対し植物性硬化油又は魚油を混合することにより、無水ケイ酸の分散性を確保できることが分かった。すなわち予め両者を機械的に分散させた予製末を用意し、これを打錠前に添加することにより、容易に均一分酸性が得られることが分かった。植物性硬化油とは不飽和の液状植物油に水素を添加し、固状の脂肪に変えたものをいう。綿実油,大豆油等を原料にしたものがあるが、ここでの植物性硬化油は川研ファインケミカル製ラブリ・ワックス−102Hを用いた。魚油とは水産動物から採取された油で、いわし油,さんま油などがあり、多くはフィッシュミールの副産物で得られる。その脂肪酸組成はEPA,DPA等の最近注目の高度不飽和酸が多く、健康増進に役立つ。本発明では魚油も硬化油の形にして使用する。
植物性硬化油の場合、無水ケイ酸との望ましい混合比は、無水ケイ酸1部に対し植物性硬化油1〜2部である。なお植物性硬化油は打錠時の滑沢剤として効果を発揮するものであり、また混合による成形性阻害は観察されなかった。植物性硬化油は魚油に比べて分散性向上に優れより好ましいものになっている。
It was considered that silicic acid anhydride has strong cohesiveness and thus does not disperse even when mechanically mixed, and sufficient uniform mixing property cannot be obtained. As a result of intensive studies, it was found that dispersibility of silicic anhydride can be ensured by mixing vegetable hardened oil or fish oil with silicic anhydride. That is, it was found that by preparing a preformed powder in which both are mechanically dispersed in advance and adding this before tableting, uniform acidity can be easily obtained. The vegetable hardened oil is obtained by adding hydrogen to an unsaturated liquid vegetable oil to convert it into a solid fat. Some of these are made from cottonseed oil, soybean oil, etc., but as the vegetable hardened oil here, Laburi Wax-102H manufactured by Kawaken Fine Chemical was used. Fish oil is an oil collected from marine animals such as sardine oil and sesame oil, and many are obtained as fishmeal by-products. The fatty acid composition has many highly unsaturated polyunsaturated acids such as EPA and DPA which are useful for health promotion. In the present invention, fish oil is also used in the form of hydrogenated oil.
In the case of vegetable hardened oil, a desirable mixing ratio with silicic anhydride is 1 to 2 parts of vegetable hardened oil to 1 part of silicic anhydride. In addition, the vegetable hardened oil exhibits an effect as a lubricant at the time of tableting, and the moldability inhibition by mixing was not observed. The vegetable hardened oil is excellent in dispersibility improvement and more preferable than fish oil.

以下、本発明を実施例に基づき詳述するが、本発明は勿論実施例に限定されるものでない。実施例に示すものに限られず、目的,用途に応じて本発明の範囲で種々変更できる。   EXAMPLES Hereinafter, although this invention is explained in full detail based on an Example, of course, this invention is not limited to an Example. It is not restricted to what is shown in an Example, According to the objective and a use, it can change variously in the range of this invention.

先ず、微粒子二酸化ケイ素(日本アユロジル製)と植物性硬化油(川研ファインケミカル)を混合比1:2で混合し混合物84gを作製する。次いで、茶葉粉末1,400gをとり、前記混合物84gを加え、さらに予め造粒したソルビトール顆粒460gを加えてこれらを混合する。こうして得られた混合体に対し先の植物性硬化油56gを均一に混合し、これを回転数40rpm−錠剤重量200mg−加圧力12MPa(1.2トンf)の条件で打錠した(株式会社菊水製コレクト12HUK)。得られた錠剤は9,600錠であった。途中打錠障害は観察されず、得られた錠剤は硬度56N(略5.6kg)を示し、官能的にも良好であった。前記ソルビトール顆粒は粉砕ソルビトールにCMC−Na及び精製水を加えて練合、乾燥、整粒を行い打錠に適した顆粒にしたものである。   First, fine particle silicon dioxide (manufactured by Nippon Ayurosil) and vegetable hardened oil (Kawaken Fine Chemical) are mixed at a mixing ratio of 1: 2 to prepare 84 g of a mixture. Next, 1,400 g of tea leaf powder is taken, 84 g of the mixture is added, and 460 g of pre-granulated sorbitol granules are added and mixed. 56 g of the above vegetable hardened oil was uniformly mixed with the mixture thus obtained, and this was tableted under the conditions of a rotation speed of 40 rpm, a tablet weight of 200 mg, and a pressure of 12 MPa (1.2 tons f) (manufactured by Kikusui Co., Ltd.). Collect 12HUK). The obtained tablets were 9,600 tablets. No tableting trouble was observed during the test, and the obtained tablet had a hardness of 56 N (approximately 5.6 kg) and was also good in terms of sensuality. The sorbitol granule is obtained by adding CMC-Na and purified water to pulverized sorbitol, kneading, drying, and sizing to make a granule suitable for tableting.

先ず、微粒子二酸化ケイ素(日本アエロジル製)と植物性硬化油(川研ファインケミカル)を混合比1:2で混合し混合物42gを作製する。次いで、茶葉粉末1,400gをとり、前記混合物42gを加え、さらに予め造粒したソルビトール顆粒502gを加えてこれらを混合する。こうして得られた混合体に対し先の植物性硬化油56gを均一に混合し、これを回転数40rpm−錠剤重量200mg−加圧力100MPa(略1.0トンf)の条件で打錠した(株式会社菊水製作所製アクア0513型)。錠剤は9,700錠得られた。途中打錠障害は観察されず、得られた錠剤は硬度51N(略5.1kg)を示し、官能的にも良好であった。   First, particulate silicon dioxide (manufactured by Nippon Aerosil Co., Ltd.) and vegetable hydrogenated oil (Kawaken Fine Chemical) are mixed at a mixing ratio of 1: 2 to prepare 42 g of a mixture. Next, 1,400 g of tea leaf powder is taken, 42 g of the mixture is added, and 502 g of pre-granulated sorbitol granules are added and mixed. 56 g of the above vegetable hardened oil was uniformly mixed with the mixture thus obtained, and tableted under the conditions of a rotation speed of 40 rpm, a tablet weight of 200 mg, and a pressing force of 100 MPa (approximately 1.0 ton f) (Kikusui Co., Ltd.). Mfg. Aqua 0513 type). 9,700 tablets were obtained. No tableting trouble was observed during the test, and the obtained tablet had a hardness of 51 N (approximately 5.1 kg) and was also good in terms of sensuality.

先ず、微粒子二酸化ケイ素(日本アエロジル製)と植物性硬化油(川研ファインケミカル)を混合比1:2で混合し混合物84gを作製する。次いで、茶葉粉末1,400gをとり、前記混合物84gを加え、さらに予め造粒したトレハロース顆粒460gを加えて混合する。こうして得られた混合体に対し先の植物性硬化油56gを均一に混合し、これを回転数20rpm−錠剤重量200mg−加圧力120MPa(略1.2トンf)の条件で打錠した。途中打錠障害は観察されず、得られた錠剤は硬度53N(略5.3kg)を示し、官能的にも良好であった。前記トレハロース顆粒はトレハロースにCMC−Na及び精製水を加えて練合、乾燥、整粒を行い打錠に適した顆粒にしたものである。   First, particulate silicon dioxide (manufactured by Nippon Aerosil Co., Ltd.) and vegetable hydrogenated oil (Kawaken Fine Chemical) are mixed at a mixing ratio of 1: 2 to prepare 84 g of a mixture. Next, 1,400 g of tea leaf powder is taken, 84 g of the mixture is added, and 460 g of pre-granulated trehalose granules are added and mixed. 56 g of the above vegetable hardened oil was uniformly mixed with the mixture thus obtained, and tableted under the conditions of a rotation speed of 20 rpm, a tablet weight of 200 mg, and a pressing force of 120 MPa (approximately 1.2 tons f). No tableting trouble was observed during the process, and the obtained tablet had a hardness of 53 N (approximately 5.3 kg) and was also good in terms of sensuality. The trehalose granule is obtained by adding CMC-Na and purified water to trehalose, kneading, drying, and sizing to obtain a granule suitable for tableting.

先ず、微粒子二酸化ケイ素(日本アエロジル製)と植物性硬化油(川研ファインケミカル)を混合比1:2で混合し混合物84gを作製する。次いで、茶葉粉末1,400gをとり、前記混合物84gを加え、さらに予め造粒したマンニトール顆粒460gを加えて混合する。こうして得られた混合体に対し先の植物性硬化油56gを均一に混合し、これを回軽数20rpm−錠剤重量200mg−加圧力120MPa(1.2トンf)の条件で打錠した。途中打錠障害は観察されず、得られた錠剤は硬度53N(略5.3kg)を示し、官能的にも良好であった。前記マンニトール顆粒は粉砕マンニトールにCMC−Na及び精製水を加えて練合、乾操、整粒を行い打錠に適した顆粒にしたものである。   First, particulate silicon dioxide (manufactured by Nippon Aerosil Co., Ltd.) and vegetable hydrogenated oil (Kawaken Fine Chemical) are mixed at a mixing ratio of 1: 2 to prepare 84 g of a mixture. Next, 1,400 g of tea leaf powder is taken, 84 g of the mixture is added, and 460 g of pre-granulated mannitol granules are added and mixed. 56 g of the above vegetable hardened oil was uniformly mixed with the mixture thus obtained, and tableted under the conditions of 20 rpm, 200 mg tablet weight, and 120 MPa (1.2 tons f). No tableting trouble was observed during the process, and the obtained tablet had a hardness of 53 N (approximately 5.3 kg) and was also good in terms of sensuality. The mannitol granules are prepared by adding CMC-Na and purified water to pulverized mannitol, kneading, drying, and sizing to form granules suitable for tableting.

先ず、微粒子二酸化ケイ素(日本アエロジル製)と植物性硬化油(川研ファインケミカル)を混合比1:1で混合し混合物112gを作製する。次いで、茶葉粉末2,800gをとり、前記混合物112gを加え、さらに予め造粒したソルビトール顆粒920gを加えて混合する。こうして得られた混合体に対し先の植物性硬化油112gを均一に混合し、これを回転数40rpm−錠剤重量200mg−加圧力200MPa(略2.0トンf)の条件で打錠した。途中打錠障害は観察されず、得られた錠剤は硬度58N(略5.8kg)を示し、官能的にも良好であった。錠剤の収量は18,000錠であった。   First, particulate silicon dioxide (manufactured by Nippon Aerosil Co., Ltd.) and vegetable hardened oil (Kawaken Fine Chemical) are mixed at a mixing ratio of 1: 1 to prepare 112 g of a mixture. Next, 2,800 g of tea leaf powder is taken, 112 g of the mixture is added, and 920 g of pre-granulated sorbitol granules are added and mixed. 112 g of the above vegetable hardened oil was uniformly mixed with the mixture thus obtained, and tableted under the conditions of a rotation speed of 40 rpm, a tablet weight of 200 mg, and a pressure of 200 MPa (approximately 2.0 tons f). No tableting trouble was observed during the process, and the obtained tablet had a hardness of 58 N (approximately 5.8 kg) and was also good in terms of sensuality. The tablet yield was 18,000 tablets.

実施例1でソルビトール顆粒の代わりにマルチトールを用いて同様に処理して錠剤を得た。得られた錠剤は10,600錠であった。途中打錠障害は観察されず、得られた錠剤は硬度62N(略6.2kg)を示し、官能的にも良好であった。   In Example 1, a tablet was obtained in the same manner using maltitol instead of sorbitol granules. The obtained tablets were 10,600 tablets. No tableting trouble was observed during the test, and the obtained tablet had a hardness of 62 N (approximately 6.2 kg) and was also good in terms of sensuality.

実施例1でソルビトール顆粒の代わりに粉末セルロースを用いて同様に処理して錠剤を得た。得られた錠剤は10,000錠であった。途中打錠障害は観察されず、得られた錠剤は硬度62N(略6.2kg)を示し、官能的にも良好であった。   In Example 1, tablets were obtained in the same manner using powdered cellulose instead of sorbitol granules. The obtained tablets were 10,000 tablets. No tableting trouble was observed during the test, and the obtained tablet had a hardness of 62 N (approximately 6.2 kg) and was also good in terms of sensuality.

実施例5でソルビトール顆粒の代わりにアマルティー(東和化成製、微粉タイプ)を用いて同様に処理して錠剤を得た。得られた錠剤は19,200錠であった。
は観察されず、錠剤は硬度58N(略5.8kg)を示し、官能的にも良好であった。
In Example 5, tablets were obtained in the same manner using amalty (manufactured by Towa Kasei, fine powder type) instead of sorbitol granules. The obtained tablets were 19,200 tablets.
No tablet was observed, and the tablet showed a hardness of 58 N (approximately 5.8 kg) and was also good in terms of sensuality.

前記実施例1〜8のいずれにおいても、茶成分が70%以上の高含量の茶錠剤で、健康増進に役立つものとなり、また製造中にキャッピングやスティッキングなどの障害もなく、生産性向上,製品の安定性につながる製法であることが確認できた。   In any of the above Examples 1 to 8, tea tablets with a high tea content of 70% or more are useful for health promotion, and there are no obstacles such as capping and sticking during production, and productivity is improved. It was confirmed that the production method leads to the stability of

Claims (3)

茶粉末と無水ケイ酸を含有して打錠成形されてなることを特徴とする茶錠剤。 A tea tablet comprising a tea powder and anhydrous silicic acid and formed into a tablet. 茶粉末と、無水ケイ酸と、植物性硬化油又は魚油と、を含有して打錠成形されてなることを特徴とする茶錠剤。 A tea tablet comprising a tea powder, silicic anhydride, and vegetable hardened oil or fish oil. 無水ケイ酸に植物性硬化油又は魚油を混合し混合物を作製し、次いで該混合物と茶粉末とを混ぜ合わせ、その後、この混ぜ合わせた混合体を、水やアルコール類を添加することなく錠剤に成形することを特徴とする茶錠剤の製造方法。 Mix the hardened vegetable oil or fish oil with silicic acid to make a mixture, then mix the mixture with tea powder, and then mix this mixture into tablets without adding water or alcohols. A method for producing a tea tablet, comprising molding.
JP2003302013A 2003-08-26 2003-08-26 Tea tablet and method for producing the same Pending JP2005065629A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003302013A JP2005065629A (en) 2003-08-26 2003-08-26 Tea tablet and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003302013A JP2005065629A (en) 2003-08-26 2003-08-26 Tea tablet and method for producing the same

Publications (1)

Publication Number Publication Date
JP2005065629A true JP2005065629A (en) 2005-03-17

Family

ID=34406471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003302013A Pending JP2005065629A (en) 2003-08-26 2003-08-26 Tea tablet and method for producing the same

Country Status (1)

Country Link
JP (1) JP2005065629A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006028171A (en) * 2004-06-15 2006-02-02 Taisho Pharmaceut Co Ltd Galenical powder-containing tablet
JP2007129976A (en) * 2005-11-11 2007-05-31 Yasuhiro Kosaka Method for producing tea tablet
JP2016074615A (en) * 2014-10-03 2016-05-12 富士カプセル株式会社 Trilaminar structure seamless capsule
JP2017178917A (en) * 2016-03-28 2017-10-05 株式会社ホットアルバム炭酸泉タブレット Solid washing agents, mineral stains washing methods, and skin or hair cosmetic methods
JP2019034974A (en) * 2018-12-05 2019-03-07 富士カプセル株式会社 Trilaminar structure seamless capsule
JP2020055869A (en) * 2019-12-26 2020-04-09 富士カプセル株式会社 Trilaminar structure seamless capsule

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006028171A (en) * 2004-06-15 2006-02-02 Taisho Pharmaceut Co Ltd Galenical powder-containing tablet
JP2007129976A (en) * 2005-11-11 2007-05-31 Yasuhiro Kosaka Method for producing tea tablet
JP2016074615A (en) * 2014-10-03 2016-05-12 富士カプセル株式会社 Trilaminar structure seamless capsule
JP2017178917A (en) * 2016-03-28 2017-10-05 株式会社ホットアルバム炭酸泉タブレット Solid washing agents, mineral stains washing methods, and skin or hair cosmetic methods
JP2019034974A (en) * 2018-12-05 2019-03-07 富士カプセル株式会社 Trilaminar structure seamless capsule
JP2020055869A (en) * 2019-12-26 2020-04-09 富士カプセル株式会社 Trilaminar structure seamless capsule
JP7222548B2 (en) 2019-12-26 2023-02-15 富士カプセル株式会社 Three-layer structure seamless capsule

Similar Documents

Publication Publication Date Title
JP5718231B2 (en) Erythritol tableting
US10085945B2 (en) Natural lubricant for direct compression and method for preparing natural tablet using the same
JP5944378B2 (en) Orally disintegrating tablets containing acarbose
WO2006063694A1 (en) Process for making bouillon or seasoning cubes
JP2005065629A (en) Tea tablet and method for producing the same
JP5751677B2 (en) Tableting of erythritol and isomalt
JP6109878B2 (en) Method for producing tablets containing cocoa powder
JP2006335686A (en) Method for producing erythritol-sorbitol mixed granule for direct tableting
JP2002065213A (en) Method for producing solid agent
JP5160156B2 (en) Nutritional functional food tablets
JP3809292B2 (en) Sugar alcohol-containing tablet composition
TW589156B (en) Method for producing a plum product
JP2003250488A (en) Food composition and method for producing the same
JP2016041662A (en) Rapidly disintegrating tablet
JP6948038B2 (en) Cinnamon powder-containing tablets and their manufacturing method
JPS6185331A (en) Production of excipient for direct tableting
JP5270791B1 (en) Granulation method of N-acetylglucosamine
JPH0586174B2 (en)
JP2004283011A (en) Method for solidifying powdery food material
JP4659573B2 (en) Tablet
JP2942411B2 (en) Poorly soluble tableted food and its manufacturing method
JP3262227B2 (en) Tablet confection having appropriate hardness and crispness and method for producing the same
JP2023041807A (en) Solid pharmaceutical composition and method for producing the same
TH2003002804C3 (en) Protein hydrolyzate chewable tablet formulation and manufacturing method
JP2020117503A (en) Oral composition

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050315

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071009

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080304